Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Visx v. Autonomous

This article was originally published in The Gray Sheet

Executive Summary

Visx files patent suit in Federal Court in Delaware seeking an injunction against Autonomous Technologies for violating a laser vision correction patent license agreement in the U.S., Visx announces Sept. 24. Terms of an April 1997 agreement allow Autonomous to manufacture and sell products based on Visx patents, but only in foreign markets. Autonomous brought suit against Visx in October 1996 seeking to have a Visx patent (4,718,418) declared invalid. Autonomous, which produces the LADARVision system, is also seeking the invalidity and unenforceability of Visx patent 4,665,913. Both patents are cited in Visx' suit

Latest Headlines
See All
UsernamePublicRestriction

Register

MT010693

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel